. The company’s pipeline incorporates 4 clinical-stage therapies. Its most Innovative drug candidate is ROS1 inhibitor taletrectinib for treating lung cancer. Nuvation is finishing two section 2 pivotal scientific tests on taletrectinib. Musk appointed Linda Yaccarino CEO of X Corp., the successor to Twitter. Because getting to be owner, https://financefeeds.com/over-700k-usdc-lost-in-defi-sandwich-attack/